During the past decade, Taipei city hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei city hospital" #1 sponsor was "Taipei City Hospital" with 24 trials, followed by "Mycenax Biotech Inc." with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "National Yang Ming University" with 2 trials sponsored and "Braeburn Pharmaceuticals" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei city hospital" #1 collaborator was "National Yang Ming University" with 4 trials as a collaborator, "Taipei City Hospital" with 2 trials as a collaborator, "Chinese Medical Association" with 1 trials as a collaborator, "National Defense Medical Center, Taiwan" with 1 trials as a collaborator and "National Research Program for Biopharmaceuticals, Taiwan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Taipei city hospital" are "Hyperlipidemia" (3 trials), "Stable Angina" (3 trials), "Quality of Life" (2 trials), "Schizophrenia" (2 trials) and "APT(Antiplatelet Therapy)" (1 trials). Many other conditions were trialed in "Taipei city hospital" in a lesser frequency.

Most popular intervention types in "Taipei city hospital" are "Drug" (12 trials), "Other" (7 trials), "Dietary Supplement" (4 trials), "Behavioral" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ENIA11" (2 trials), "BI 409306 10 mg QD" (1 trials), "BI 409306 100 mg QD" (1 trials) and "BI 425809 dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taipei city hospital" are 29 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Taipei city hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Taipei city hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Taipei city hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

Taipei city hospital has several departments that took part in Clinical trials: "Ren-Ai Branch, Taipei Municipal Hospital" - 13 trials, "Branch of Chinese Medicine, Taipei City Hospital" - 4 trials, "Taipei City Hospital Zhong-Xing branch" - 3 trials, "Departments of Psychiatry, Taipei City Hospital Yang-Ming Campus" - 2 trials